UTI Healthcare Fund Regular IDCW | UTI Healthcare Fund NAV Today [212.69], Performance & History

UTI Healthcare Fund is a Equity mutual fund categorized under Sector, offered by UTI Asset Management Co. Ltd.. Launched on 27 May 1999, investors can start with a minimum SIP of ₹100 or a lumpsum ... Read more

NAV History

Fund Details

Min. SIP Amount

₹500

Inception Date

27 May 1999

Min. Lumpsum Amount

₹ 5,000

Fund Age

26 Yrs

AUM

₹ 1,106.71 Cr.

Benchmark

BSE Healthcare Total Return

Expense Ratio

2.27%

Scheme Type

Open Ended

Exit Load

Returns Calculator

Investment amount per month

₹1,000

Over the past

Would have become

On total investment of

*Calculation based on past performance of this fund.

Asset Allocation

AUM

₹ 1,106.71 Cr

Equity

195.55%

Debt

0.02%

Other Assets & Liabilities

4.45%

Sector Holdings

Sectors	Weightage
Pharmaceuticals	74.96%
Hospitals & Medical Services	22.01%
Current Assets	1.79%
Chemicals - Speciality	0.98%
Medical Equipment & Accessories	0.26%
Short Term Deposits	0.01%

See All

Stock Holdings

Name	Weightage	Value (in Cr.)	Sector
SUN PHARMACEUTICALS INDUSTRIES	9.42%	₹ 104.22	Pharmaceuticals
AJANTA PHARMA LTD.	7.04%	₹ 77.94	Pharmaceuticals
LUPIN LTD.	5.79%	₹ 64.04	Pharmaceuticals
GLENMARK PHARMACEUTICALS LTD.	4.25%	₹ 47.01	Pharmaceuticals
APOLLO HOSPITALS ENTERPRISE LT	3.75%	₹ 41.45	Hospitals & Medical Services
GLAND PHARMA LTD.	3.54%	₹ 39.22	Pharmaceuticals
DIVIS LABORATORIES LTD.	3.52%	₹ 38.92	Pharmaceuticals
DR REDDYS LABORATORIES LTD.	3.48%	₹ 38.52	Pharmaceuticals
ALKEM LABORATORIES LTD	3.47%	₹ 38.35	Pharmaceuticals
FORTIS HEALTHCARE LTD.	2.98%	₹ 32.99	Hospitals & Medical Services
MAX HEALTHCARE INSTITUTE LTD	2.85%	₹ 31.51	Hospitals & Medical Services
AUROBINDO PHARMA LTD.	2.66%	₹ 29.45	Pharmaceuticals
COHANCE LIFESCIENCES LIMITED	2.66%	₹ 29.45	Pharmaceuticals
CAPLIN POINT LABORATORIES LTD	2.23%	₹ 24.65	Pharmaceuticals
PROCTOR & GAMBLE HEALTH LTD	2.21%	₹ 24.50	Pharmaceuticals
SUDEEP PHARMA LIMITED	2.19%	₹ 24.18	Pharmaceuticals
IPCA LABORATORIES LTD.	2.17%	₹ 24.03	Pharmaceuticals
VIYASH SCIENTIFIC LTD	2.11%	₹ 23.31	Pharmaceuticals
SAI LIFE SCIENCES LTD	2.07%	₹ 22.92	Pharmaceuticals
JUPITER LIFE LINE HOSPITALS LTD	2.06%	₹ 22.79	Hospitals & Medical Services
GLOBAL HEALTH LTD.	2.02%	₹ 22.33	Hospitals & Medical Services
ASTER DM HEALTHCARE LTD	1.94%	₹ 21.52	Hospitals & Medical Services
ANTHEM BIOSCIENCES LTD	1.91%	₹ 21.17	Pharmaceuticals
ERIS LIFESCIENCES LTD	1.84%	₹ 20.37	Pharmaceuticals
CIPLA LTD.	1.83%	₹ 20.22	Pharmaceuticals
NET CURRENT ASSETS	1.79%	₹ 19.77	Others
PFIZER LIMITED	1.77%	₹ 19.54	Pharmaceuticals
METROPOLIS HEALTHCARE LTD	1.66%	₹ 18.41	Hospitals & Medical Services
MARKSANS PHARMA LTD.	1.65%	₹ 18.26	Pharmaceuticals
KRISHNA INSTITUTE OF MEDI SCIE	1.55%	₹ 17.15	Hospitals & Medical Services
DR LAL PATHLABS LTD.	1.26%	₹ 14	Hospitals & Medical Services
WINDLAS BIOTEC LTD	1.13%	₹ 12.50	Pharmaceuticals
VIJAYA DIAGNOSTIC CENTRE LTD	1.09%	₹ 12.05	Hospitals & Medical Services
ACUTAAS CHEMICALS LIMITED	1.07%	₹ 11.87	Pharmaceuticals
SANOFI CONSUMER HEALTHCARE INDIA LTD	0.98%	₹ 10.85	Chemicals - Speciality
EMCURE PHARMACEUTICALS LTD	0.94%	₹ 10.45	Pharmaceuticals
RAINBOW CHILDRENS MEDICARE LTD	0.85%	₹ 9.36	Hospitals & Medical Services
AARTI PHARMALABS LTD	0.84%	₹ 9.27	Pharmaceuticals
JUBILANT PHARMOVA LIMITED	0.70%	₹ 7.77	Pharmaceuticals
BIOCON LTD.	0.70%	₹ 7.80	Pharmaceuticals
SYNGENE INTERNATIONAL LTD.	0.69%	₹ 7.60	Pharmaceuticals
ORCHID PHARMA LTD.	0.56%	₹ 6.20	Pharmaceuticals
ALEMBIC PHARMACEUTICALS	0.52%	₹ 5.78	Pharmaceuticals
LAXMI DENTAL LIMITED	0.26%	₹ 2.92	Medical Equipment & Accessories
CLEARING CORPORATION OF INDIA LTD. STD - MARGIN	0.01%	₹ 0.09	Others

See All

Returns

	Annualised returns
	9M	1Y	2Y	3Y
Fund returns	-2.80%	2.97%	11.62%	24.72%
Category returns	-6.96%	1.07%	6.24%	23.23%

Fund Objective

An open-ended fund which exclusively invests in the equities of the Pharma & Healthcare sector companies. This fund is one of the growth sector funds aiming to invest in companies engaged in ... Read more

AMC Details

Name

UTI Asset Management Co. Ltd.

Date of Incorporation

01 Feb 2003

CEO

Mr. Vetri Subramaniam

CIO

Mr Vetri Subramaniam

Type

Bank Sponsored

Address

UTI Towers, Gn Block, Bandra Kurla Complex, Bandra (East), Mumbai, Maharashtra, India - 400051

Website

https://www.utimf.com

[email protected]

Top Funds from Equity - Sectoral/Thematic

Scheme Name	NAV	Returns 1Y 3Y 5Y			AUM (Cr)	Expense Ratio	Risk Meter
Canara Robeco Consumer Trends Fund - Direct Plan Diversified Direct	₹75.07	-9.30%	32.38%	54.69%	₹1,950	0.82%	Very High
Canara Robeco Consumer Trends Fund - Direct Plan Diversified Direct	₹75.07	-9.30%	32.38%	54.69%	₹1,950	0.82%	Very High
Quantum ESG Best In Class Strategy Fund Diversified Regular	₹20.89	-6.99%	32.30%	47.42%	₹95	2.18%	Very High
DSP Quant Fund Largecap Regular	₹19.83	-1.18%	32.19%	43.66%	₹838	1.25%	Very High
SBI Technology Opportunities Fund Sector Regular	₹108.99	-9.58%	32.11%	72.26%	₹4,273	1.92%	Very High
SBI Technology Opportunities Fund Sector Regular	₹108.99	-9.58%	32.11%	72.26%	₹4,273	1.92%	Very High
SBI Technology Opportunities Fund Sector Regular	₹180.99	-9.58%	32.10%	72.24%	₹4,273	1.92%	Very High
Axis Innovation Fund - Direct Plan Diversified Direct	₹15.31	-5.26%	32.10%	49.80%	₹1,121	1.31%	Very High
Axis Innovation Fund - Direct Plan Sector Direct	₹15.31	-5.26%	32.10%	49.80%	₹1,121	1.31%	Very High
Tata Ethical Fund - Direct Plan Sector Direct	₹215.33	-5.17%	31.65%	66.52%	₹3,715	0.71%	Very High

Top Funds from UTI Asset Management Co. Ltd.

Scheme Name	NAV	Returns 1Y 3Y 5Y			AUM (Cr)	Expense Ratio	Risk Meter
UTI Equity Savings Fund Hybrid Regular	₹18.34	3.55%	32.86%	54.72%	₹835	1.65%	Moderate
UTI Equity Savings Fund Hybrid Regular	₹18.34	3.55%	32.86%	54.72%	₹835	1.65%	Moderate
UTI Equity Savings Fund Hybrid Regular	₹18.34	3.55%	32.86%	54.72%	₹835	1.65%	Moderate
UTI Equity Savings Fund Hybrid Regular	₹18.34	3.55%	32.86%	54.72%	₹835	1.65%	Moderate
UTI Equity Savings Fund Hybrid Regular	₹18.34	3.55%	32.86%	54.72%	₹835	1.65%	Moderate
UTI Equity Savings Fund Hybrid Regular	₹18.34	3.55%	32.86%	54.72%	₹835	1.65%	Moderate
UTI Equity Savings Fund Hybrid Regular	₹18.34	3.55%	32.86%	54.72%	₹835	1.65%	Moderate
UTI BSE Sensex ETF ETF Regular	₹809.72	-4.14%	32.13%	58.82%	₹53,583	0.05%	Very High
UTI BSE Sensex Index Fund - Direct Plan Index Direct	₹13.22	-4.29%	31.32%	0.00%	₹203	0.19%	Very High
UTI BSE Sensex Index Fund Index Regular	₹13.17	-4.39%	30.94%	0.00%	₹203	0.29%	Very High

FAQs

What is the current NAV of UTI Healthcare Fund Regular IDCW?

The current Net Asset Value (NAV) of UTI Healthcare Fund Regular IDCW is ₹212.69 as of 27 Mar 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.

What is the fund size (AUM) of UTI Healthcare Fund Regular IDCW?

The Assets Under Management (AUM) of UTI Healthcare Fund Regular IDCW is ₹1,106.71 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.

What are the historical returns of UTI Healthcare Fund Regular IDCW?

UTI Healthcare Fund Regular IDCW has delivered returns of 2.97% (1 Year), 24.72% (3 Year), 15.14% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.

What is the risk level of UTI Healthcare Fund Regular IDCW?

UTI Healthcare Fund Regular IDCW has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.

What is the minimum investment amount for UTI Healthcare Fund Regular IDCW?

The minimum lumpsum investment required for UTI Healthcare Fund Regular IDCW is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹500, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article